205 related articles for article (PubMed ID: 8049289)
1. [The antigenemia test for cytomegalovirus].
Pérez JL; Salvà J; Niubó J
Enferm Infecc Microbiol Clin; 1994 May; 12(5):251-61. PubMed ID: 8049289
[No Abstract] [Full Text] [Related]
2. Virological diagnosis of cytomegalovirus in renal transplantation: comparison of three diagnostic methods: DNA in plasma by PCR, PP65 leukocytic antigenemia, and viremia.
Eckart P; Brouard J; Legoff C; Freymuth F; Duhamel JF; Ryckelynck JP; Hurault De Ligny B
Transplant Proc; 1996 Oct; 28(5):2806-7. PubMed ID: 8908069
[No Abstract] [Full Text] [Related]
3. Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation.
Ksouri H; Eljed H; Greco A; Lakhal A; Torjman L; Abdelkefi A; Ben Othmen T; Ladeb S; Slim A; Zouari B; Abdeladhim A; Ben Hassen A
Transpl Infect Dis; 2007 Mar; 9(1):16-21. PubMed ID: 17313466
[TBL] [Abstract][Full Text] [Related]
4. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of CMV infection: a comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation.
Hebart H; Müller C; Löffler J; Jahn G; Einsele H
Bone Marrow Transplant; 1996 May; 17(5):861-8. PubMed ID: 8733710
[TBL] [Abstract][Full Text] [Related]
6. [Comparison between 2 monoclonal antibodies (clones 95/12 and 1C3 + AYm-1) for the detection of pp65 antigenemia associated with human cytomegalovirus].
Reina J; Munar M; Blanco I
Enferm Infecc Microbiol Clin; 1998; 16(6):269-71. PubMed ID: 9763743
[TBL] [Abstract][Full Text] [Related]
7. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G
Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893
[TBL] [Abstract][Full Text] [Related]
8. [The prognostic value of cytomegalovirus antigenemia and viremia for the development of cytomegalovirus disease and the survival of AIDS patients].
Cartón JA; Maradona JA; de Oña M; Asensi V; Melón S; García-Alcalde ML; Rodríguez-Junquera M; Moreno-Torrico A; de Zárraga M
Med Clin (Barc); 1999 Sep; 113(6):205-9. PubMed ID: 10472608
[TBL] [Abstract][Full Text] [Related]
9. A multisite trial comparing two cytomegalovirus (CMV) pp65 antigenemia test kits, biotest CMV brite and Bartels/Argene CMV antigenemia.
St George K; Boyd MJ; Lipson SM; Ferguson D; Cartmell GF; Falk LH; Rinaldo CR; Landry ML
J Clin Microbiol; 2000 Apr; 38(4):1430-3. PubMed ID: 10747120
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of the cytomegalovirus (CMV) antigenemia assay for predicting the occurrence of CMV disease and death in patients with AIDS.
Chevret S; Scieux C; Garrait V; Dahel L; Morinet F; Modaï J; Decazes JM; Molina JM
Clin Infect Dis; 1999 Apr; 28(4):758-63. PubMed ID: 10825035
[TBL] [Abstract][Full Text] [Related]
11. Comparison of viral culture, pp-65 antigenemia, and polymerase chain reaction for the detection of cytomegalovirus in blood specimens from renal transplant recipients.
Segondy M; Mourad G; Boumzebra A; Montes B; Leray H
Transplant Proc; 1996 Oct; 28(5):2810. PubMed ID: 8908071
[No Abstract] [Full Text] [Related]
12. Comparison of pp65 antigenemia, quantitative PCR and DNA hybrid capture for detection of cytomegalovirus in transplant recipients and AIDS patients.
Mhiri L; Kaabi B; Houimel M; Arrouji Z; Slim A
J Virol Methods; 2007 Jul; 143(1):23-8. PubMed ID: 17336402
[TBL] [Abstract][Full Text] [Related]
13. Comparison between RFLP-PCR and antigenemia for pp65 antigen for diagnosis of cytomegalovirus disease after kidney transplantation.
Schröeder R; Michelon T; Fagundes I; Bortolotto A; Petry M; Lammerhirt E; Santos L; Cantarelli V; Keitel E; Garcia V; Neumann J
Transplant Proc; 2004 May; 36(4):891-3. PubMed ID: 15194306
[TBL] [Abstract][Full Text] [Related]
14. A double-blinded, prospective study to define antigenemia and quantitative real-time polymerase chain reaction cutoffs to start preemptive therapy in low-risk, seropositive, renal transplanted recipients.
David-Neto E; Triboni AH; Paula FJ; Vilas Boas LS; Machado CM; Agena F; Latif AZ; Alencar CS; Pierrotti LC; Nahas WC; Caiaffa-Filho HH; Pannuti CS
Transplantation; 2014 Nov; 98(10):1077-81. PubMed ID: 24839894
[TBL] [Abstract][Full Text] [Related]
15. Surveillance of cytomegalovirus after solid-organ transplantation: comparison of pp65 antigenemia assay with a quantitative DNA hybridization assay.
Bossart W; Bienz K; Wunderli W
J Clin Microbiol; 1997 Dec; 35(12):3303-4. PubMed ID: 9399540
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of CMV Brite kit for detection of cytomegalovirus pp65 antigenemia in peripheral blood leukocytes by immunofluorescence.
Landry ML; Ferguson D; Stevens-Ayers T; de Jonge MW; Boeckh M
J Clin Microbiol; 1996 May; 34(5):1337-9. PubMed ID: 8727936
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte concentration in the performance of the pp65 antigenemia assay.
Lipson SM; Della-Latta P
J Clin Microbiol; 2000 Aug; 38(8):3137-8. PubMed ID: 11001666
[No Abstract] [Full Text] [Related]
18. Use of PCR serum in diagnosing and monitoring cytomegalovirus reactivation in bone marrow transplant recipients.
Matsunaga T; Sakamaki S; Ishigaki S; Kohda K; Takeda M; Katoh J; Kuroda H; Hirayama Y; Kusakabe T; Akiyama T; Kuga T; Niitsu Y; Masaoka T; Sagawa T; Matsumoto Y
Int J Hematol; 1999 Feb; 69(2):105-11. PubMed ID: 10071460
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.
Yakushiji K; Gondo H; Kamezaki K; Shigematsu K; Hayashi S; Kuroiwa M; Taniguchi S; Ohno Y; Takase K; Numata A; Aoki K; Kato K; Nagafuji K; Shimoda K; Okamura T; Kinukawa N; Kasuga N; Sata M; Harada M
Bone Marrow Transplant; 2002 Apr; 29(7):599-606. PubMed ID: 11979310
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of rapid methods of detecting cytomegalovirus in the blood of renal transplant recipients in relation to patient and graft survival.
Eriksson BM; Wirgart BZ; Claesson K; Tufveson G; Magnusson G; Tötterman T; Grillner L
Clin Transplant; 1996 Dec; 10(6 Pt 1):494-502. PubMed ID: 8996769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
